Projects

Intellipharmaceutics International, a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral…
Read More...

Finch Therapeutics, Inc., a microbiome therapeutics company, and OpenBiome, a leading public stool bank announced a collaboration to develop FIN-403, an orally administered microbial…
Read More...

Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced that it has entered into a collaboration with Frenova Renal…
Read More...

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an…
Read More...

Abzena has entered into a manufacturing agreement with University College London (UCL). Under the agreement, Abzena will manufacture Magacizumab, an antibody created using the…
Read More...

Allergan plc announced that it has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company. Allergan acquired LifeCell for approximately…
Read More...

West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland. The expansion is in response to…
Read More...

Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence,…
Read More...

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its…
Read More...

Merck, a leading science and technology company, announced an investment of more than € 50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in…
Read More...